fda warning peptides bpc 157 tb 500 TB-500 – Research Peptide FDA to discuss easing restrictions

Abnormal dreams, abnormal thinking, anxiety, asthenia, confusion, depression, euphoria, extrapyramidal symptoms, hallucinations, hyperkinesis, inability to concentrate, insomnia, nervousness, paresthesias, somnolence, stupor, tremor, vertigo, and malaise have been reported in less than 1% of patients during clinical trials for ketorolac or other NSAIDs

Contact us if you have any concerns.

Although BPC 157 has shown promising results in preclinical studies, further research and clinical trials need to be done in order to determine its potential therapeutic application and safety in humans

The preservative stops bacteria from growing, so one vial stays usable for repeated draws

Reduces Inflammation Certain ingredients, such as glutathione with vitamin C, can help with inflammation